| Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer G Draisma, R Boer, SJ Otto, IW van der Cruijsen, RAM Damhuis, ... Journal of the National Cancer Institute 95 (12), 868-878, 2003 | 1398 | 2003 |
| Overdiagnosis due to prostate-specific antigen screening: lessons from US prostate cancer incidence trends R Etzioni, DF Penson, JM Legler, D Di Tommaso, R Boer, PH Gann, ... Journal of the National Cancer Institute 94 (13), 981-990, 2002 | 1208 | 2002 |
| Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review SJ Otto, J Fracheboud, CWN Looman, MJM Broeders, R Boer, ... The Lancet 361 (9367), 1411-1417, 2003 | 472 | 2003 |
| MHC polymorphism under host-pathogen coevolution JAM Borghans, JB Beltman, RJ De Boer Immunogenetics 55, 732-739, 2004 | 351 | 2004 |
| The effect of group size on time budgets and social behaviour in wild long-tailed macaques (Macaca fascicularis) CP Van Schaik, MA Van Noordwijk, RJ de Boer, I den Tonkelaar Behavioral ecology and sociobiology 13, 173-181, 1983 | 275 | 1983 |
| A model for a smallpox-vaccination policy SA Bozzette, R Boer, V Bhatnagar, JL Brower, EB Keeler, SC Morton, ... New England Journal of Medicine 348 (5), 416-425, 2003 | 261 | 2003 |
| Endoscopic colorectal cancer screening: a cost-saving analysis F Loeve, ML Brown, R Boer, M van Ballegooijen, GJ van Oortmarssen, ... JNCI: Journal of the National Cancer Institute 92 (7), 557-563, 2000 | 238 | 2000 |
| The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening F Loeve, R Boer, GJ van Oortmarssen, M van Ballegooijen, ... Computers and Biomedical Research 32 (1), 13-33, 1999 | 237 | 1999 |
| How much can current interventions reduce colorectal cancer mortality in the US? Mortality projections for scenarios of risk‐factor modification, screening, and treatment I Vogelaar, M Van Ballegooijen, D Schrag, R Boer, SJ Winawer, ... Cancer 107 (7), 1624-1633, 2006 | 232 | 2006 |
| Neighborhood design and walking trips in ten US metropolitan areas R Boer, Y Zheng, A Overton, GK Ridgeway, DA Cohen American journal of preventive medicine 32 (4), 298-304, 2007 | 228 | 2007 |
| Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials HJ Koning, R Boer, PG Warmerdam, PMM Beemsterboer, PJM van JNCI: Journal of the National Cancer Institute 87 (16), 1217-1223, 1995 | 216 | 1995 |
| Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trial HJ de Koning, MK Liem, CA Baan, R Boer, FH Schröder, ... International Journal of Cancer 98 (2), 268-273, 2002 | 203 | 2002 |
| Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975–2000 SH Moolgavkar, TR Holford, DT Levy, CY Kong, M Foy, L Clarke, J Jeon, ... Journal of the National Cancer Institute 104 (7), 541-548, 2012 | 194 | 2012 |
| National Polyp Study data: evidence for regression of adenomas F Loeve, R Boer, AG Zauber, M Van Ballegooijen, GJ Van Oortmarssen, ... International journal of cancer 111 (4), 633-639, 2004 | 182 | 2004 |
| Cost-effectiveness of cervical cancer screening: comparison of screening policies ME van den Akker-van Marle, M van Ballegooijen, GJ van Oortmarssen, ... Journal of the National cancer institute 94 (3), 193-204, 2002 | 172 | 2002 |
| Cost-effectiveness of cervical cancer screening: comparison of screening policies ME van den Akker-van Marle, M van Ballegooijen, GJ van Oortmarssen, ... Journal of the National cancer institute 94 (3), 193-204, 2002 | 172 | 2002 |
| Cost-effectiveness of cervical cancer screening: comparison of screening policies ME van den Akker-van Marle, M van Ballegooijen, GJ van Oortmarssen, ... Journal of the National cancer institute 94 (3), 193-204, 2002 | 172 | 2002 |
| Current and future applications of dried blood spots in viral disease management IJM Snijdewind, JJA van Kampen, PLA Fraaij, ME van der Ende, ... Antiviral research 93 (3), 309-321, 2012 | 154 | 2012 |
| Nation‐wide breast cancer screening in The Netherlands: Results of initial and subsequent screening 1990–1995 J Fracheboud, HJ de Koning, PMM Beemsterboer, R Boer, ... International journal of cancer 75 (5), 694-698, 1998 | 150 | 1998 |
| Mammography screening and risk of breast cancer death: a population-based case–control study SJ Otto, J Fracheboud, ALM Verbeek, R Boer, JCIY Reijerink-Verheij, ... Cancer epidemiology, biomarkers & prevention 21 (1), 66-73, 2012 | 148 | 2012 |
